NCT04182100 2025-09-15
Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
PharmaEssentia Japan K.K.
Phase 2 Completed
PharmaEssentia Japan K.K.
PharmaEssentia
Sumitomo Pharma Switzerland GmbH
PharmaEssentia Japan K.K.
Angle plc
iSpecimen Inc
Clinical Genomics Pathology
Immunicon
Immunicon